Monitoring of virological response and acquired HIV-1 drug resistance among patients initiating antiretroviral therapy in the centre region of Cameroon
viral load monitoring reveals poor ART response in rural settings, which prompts the need for improving access to ART. Among those with unsuppressed VL, the burden and patterns of HIVDR are similar in both settings, likely due to the wide use of NNRTI-based ART. Viral susceptibility to INSTIs supports a possible switch to dolutegravir-based ART for optimal response.
Authors
- Patrick Valère Tsouh Fokou (ORCID: https://orcid.org/0000-0003-3724-3527)
- Evariste Molimbou
- Fokam Jm
- Jerome Fru-Cho
- Ezéchiel Ngoufack Jagni Semengue (ORCID: https://orcid.org/0000-0001-8768-2371)
- Christopher Dächert (ORCID: https://orcid.org/0000-0001-6441-3099)
- Josef Eberle (ORCID: https://orcid.org/0000-0001-6770-0309)
- Oliver Bosnjak
- Naomi-Karell Etame (ORCID: https://orcid.org/0009-0004-4320-0982)
- Stefanie Van Cleaf
- Patrick Achiangia Njukeng (ORCID: https://orcid.org/0000-0001-5265-1612)
- Bello Djoda
- Maximilian Muenchhoff
- Bauer Wilhelm
- Oliver Till Keppler
- Rodrigue Kamga
- Abel Wade
- Alain Nantchouang Megaptche
- Charles Fokounang
Institutions
- Université de Yaoundé I (CM)
- University of Buea (CM)
- Zimmer Biomet (Netherlands) (NL)
- University of Bamenda (CM)
- Centre International De Reference Chantal Biya (CM)
- Ludwig-Maximilians-Universität München (DE)
- Leipzig University (DE)
Publication Details
- Journal
- Pan African Medical Journal
- Published
- 2025-11-21
- DOI
- https://doi.org/10.11604/pamj.2025.52.122.46773
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00